“We think it’s a pathway to a new approach to get long-term remission, and then ultimately a cure,” he said. “We’re not there yet, but we think we’re getting such encouraging results.” Changes to CAR ...

The adaptive, biomarker-directed trial allows researchers to enrich for best responders and open new sub-studies for non-responders based on emerging data.